arcadia biosciences share price

Explore strong dividend paying companies in the Food, Beverage & Tobacco industry. How has the Arcadia Biosciences Inc share price performed this year? Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings. Here’s Why This Is Going to Be a Blockbuster Deal. Visit a quote page and your recently viewed tickers will be displayed here. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Stable Share Price: RKDA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week. What Kind Of Shareholder Owns Most Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock? RKDA is unprofitable, and losses have increased over the past 5 years at a rate of 0.5% per year. Here are the trading details for Arcadia Biosciences Inc: Based on an overall assessment of its quality, value and momentum, Arcadia Biosciences Inc is currently classified as a Sucker Stock. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives. Below Fair Value: Insufficient data to calculate RKDA's fair value to establish if it is undervalued. Miami Marlins hire Kim Ng — she’s the first woman GM of a men’s pro sports team in the U.S. agencies. -0.1  -2.7%. in the past year, with total shares outstanding growing by 23.8%. (-205.41%), as it is currently unprofitable. /* sc-component-id: sc-RefOD */ Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. .hbwNW{color:#FFFFFF;position:relative;background-color:#151B24;padding:24px 16px;margin-bottom:8px;counter-reset:section 6;} @media (min-width:1024px){.hbwNW{padding:32px;margin-bottom:24px;}}.hdplEo{color:#FFFFFF;position:relative;background-color:#151B24;padding:24px 16px;margin-bottom:8px;counter-reset:section 7;} @media (min-width:1024px){.hdplEo{padding:32px;margin-bottom:24px;}} Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. to determine if its dividend payments are covered by earnings. Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. 337927). $2.9 Subscriber Agreement & Terms of Use, ($USD581.08K) is about average for companies of similar size in the US market ($USD563.91K). Historical and current end-of-day data provided by FACTSET. Lowernet loss reflects Change in fair value of common stock warincrease from $987K to $5.1M (income), Offering costsdecrease from $365K (expense) to $0K. To invest in , you'll need to open an account.Try our handy filter to find which one suits you best. (2018). PE vs Market: RKDA is unprofitable, so we can't compare its PE Ratio to the US market. : For the six months ended 30 June 2020, ArcadiaBiosciences Inc revenues increased 63% to $590K. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. GE’s Cash Pile Is Holding Up as Its Business Changes, Fed’s Bullard downplays need for additional massive fiscal stimulus, says job market recovery has been much stronger than last recession, Biden Could Have a Surprising Impact on Oil Prices, Here are 20 stocks that may benefit as investors rotate money into cyclical sectors. Intraday Data provided by FACTSET and subject to terms of use. Arcadia Biosciences stock selloff comes after a 245% rally over the prior 2 sessions MarketWatch. View recent trades and share price information for Arcadia Biosciences Inc USD0.001 Price trends tend to persist, so it's worth looking at them when it comes to a share like Arcadia Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been -35.84%. The high price target for RKDA is $16.00 and the low price target for RKDA is $12.00. Unable to evaluate RKDA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. Stable Share Price: RKDA is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week. Geographically, it operates from in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. (11%) has been stable over the past year, but is still higher than 75% of US stocks. Have Watchlists? Volatility Over Time: RKDA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks. This browser is no longer supported at MarketWatch. Arcadia Biosciences' stock up on heavy volume again, but pulls way back from earlier peak MarketWatch. £24.3m. Please read our Financial Services Guide before deciding whether to obtain financial services from us. Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The selling price currently displayed is higher than the buying price. For the best MarketWatch.com experience, please update to a modern browser. -28.02% over the past 365 days. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. Hargreaves Lansdown is not responsible for an It is doubtless a positive to see that the Arcadia Biosciences, Inc. (NASDAQ:RKDA) share price has gained some 69% in the last three months. Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. Notable Dividend: Unable to evaluate RKDA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts. Founder of Dovedale Investments LLC, Lilian S. Murray is on the board of Arcadia Biosciences, Inc. and Manager of Dovedale Investments LLC and Healthcare Partner at Ponte Partners. Forecast Cash Runway: RKDA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.3% each year. DoorDash Files for IPO. The latest Arcadia Biosciences Inc USD0.001 share price. We may not share Matt's compensation has been consistent with company performance over the past year. Dividend information for this stock is not available. Arguably, the recent bounce is to be expected after such a bad drop. Future Dividend Coverage: No need to calculate the sustainability of RKDA's dividend in 3 years as they are not forecast to pay a notable one for the US market. ( 1.2 years average tenure), which suggests a new team. © 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POOR’S FINANCIAL SERVICES LLC. Their average twelve-month price target is $14.00, predicting that the stock has a possible upside of 333.44%. and the price has moved by For more information, learn about our StockRank Styles. The portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. Producer Prices Climbed More Than Expected in October. Arcadia Biosciences Inc (NASDAQ:RKDA) Share Price and News. Despite being -12.29% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 17 when the RKDA stock price touched $3.58-1 or saw a rise of 14.25%. Arcadia Biosciences Stock Price Forecast, RKDA stock price prediction. Create a list of the investments you want to track. The overall consensus recommendation for Arcadia Biosciences Inc is Buy. In terms of relative price strength - which takes into account the overall market trend - the Arcadia Biosciences Inc price has moved by Arcadia Biosciences Inc (NASDAQ:RKDA)’s share price crossed below its 50-day moving average during trading on Wednesday . The company’s crop productivity t, Unless specified all financial data is based on a yearly period but updated quarterly. here to help. Experienced Board: RKDA's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. 2 Wall Street analysts have issued ratings and price targets for Arcadia Biosciences in the last 12 months. An important predictor of whether a stock price will go up is its track record of momentum. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Something went wrong while loading Watchlist. Arcadia Biosciences, Inc.'s company bio, employee growth, exchange listings and data sources, Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. Try our handy filter to explore the different options. RKDA is unprofitable, so we can't compare its, RKDA is unprofitable, so we can't compare its.

Lord Protector Synonym, Roger Bannister Family, Best Air Cooler 2020, How To Make Spicy Ramen Better, Oscar Mayer Bacon Naturally Hardwood Smoked 16 Oz, Gordon Ramsay Beans, Forever Mine Meaning In Kannada, Ps4 Flight Stick,

No intelligent comments yet. Please leave one of your own!

Leave a Reply